Related references
Note: Only part of the references are listed.ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth
Mark Pimentel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Obesity increases the risk of small intestinal bacterial overgrowth (SIBO)
B. C. Roland et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2018)
Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease
Lars K. Gjaerde et al.
BONE MARROW TRANSPLANTATION (2018)
Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review
Natalia Pittman et al.
RHEUMATOLOGY (2018)
The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation
Bertrand Routy et al.
ONCOIMMUNOLOGY (2017)
Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth A Meta-Analysis and Systematic Review of Current Evidence
Changqing Zhong et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2017)
Is-it possible to distinguish irritable bowel syndrome with constipation from functional constipation?
M. Bouchoucha et al.
TECHNIQUES IN COLOPROCTOLOGY (2017)
Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus
Ali Rezaie et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth
L. Gatta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Is irritable bowel syndrome an infectious disease?
John Richard Thompson
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Irritable bowel syndrome
Paul Enck et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Role of Gut Microbiota in Liver Disease
David A. Brenner et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
Determination of Rifaximin Treatment Period According to Lactulose Breath Test Values in Nonconstipated Irritable Bowel Syndrome Subjects
Suhyun Bae et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
Glucose breath test and Crohn's disease: Diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response
Anna Greco et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
Patients with irritable bowel syndrome and constipation are more depressed than patients with functional constipation
Michel Bouchoucha et al.
DIGESTIVE AND LIVER DISEASE (2014)
Antibiotic Treatment of Constipation-Predominant Irritable Bowel Syndrome
Mark Pimentel et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Small intestinal bacterial overgrowth is common both among patients with alcoholic and idiopathic chronic pancreatitis
Kundan Kumar et al.
PANCREATOLOGY (2014)
Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth
S. C. Shah et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Rifaximin in irritable bowel syndrome: rationale, evidence and clinical use
Mohammed Saadi et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2013)
Effect of Probiotic or Prebiotic Supplementation on Antibiotic Therapy in the Small Intestinal Bacterial Overgrowth: A Comparative Evaluation
Rosa Rosania et al.
CURRENT CLINICAL PHARMACOLOGY (2013)
Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Ying Taur et al.
CLINICAL INFECTIOUS DISEASES (2012)
Review of rifaximin as treatment for SIBO and IBS
Mark Pimentel
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin
Sergio Peralta et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: A contributor to severe hepatic steatosis
Jean-Marc Sabate et al.
OBESITY SURGERY (2008)
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
Iris Posserud et al.
GUT (2007)
Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth
Marek Majewski et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2007)
Small intestinal bacterial overgrowth: Roles of antibiotics, prebiotics, and Probiotics
EMM Quigley et al.
GASTROENTEROLOGY (2006)
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth
EC Lauritano et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
The placebo response in functional bowel disorders: perspectives and putative mechanisms
P Enck et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2005)
Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon
Antonio Tursi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Treatment of small intestine bacterial overgrowth and related symptoms by rifaximin
M Di Stefano et al.
CHEMOTHERAPY (2005)
Share Paper
